Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
restructuring
Pharma
Teva's subdued outlook puts damper on strong 2024 results
Despite finishing strong in 2024, Teva’s cautious approach to the new year appears to have investors spooked.
Fraiser Kansteiner
Jan 29, 2025 1:13pm
JPM25: Recovering Emergent inks deal for opioid overdose spray
Jan 15, 2025 7:41pm
Deloitte outlines key areas for biopharma to watch in 2025
Dec 26, 2024 8:00am
Lonza aims to shed capsules business, restructure CDMO offerings
Dec 12, 2024 8:58am
EuroAPI taps new CEO from within its ranks
Dec 9, 2024 4:15pm
Agenus to offer CDMO services, lay off staffers in latest reorg
Dec 5, 2024 7:51am
